A multi-center phase Ib study of oxaliplatin (NSC#266046) in combination with fluorouracil and leucovorin in pediatric patients with advanced solid tumors

Margaret E. Macy; Tracey Duncan; James Whitlock; Stephen P. Hunger; Jessica Boklan; Aru Narendran; Cynthia Herzog; Robert J. Arceci; Rochelle Bagatell; Tanya Trippett; Uwe Christians; Katherine Rolla; S. Percy Ivy; Lia Gore;

doi:10.1002/pbc.24278

A multi-center phase Ib study of oxaliplatin (NSC#266046) in combination with fluorouracil and leucovorin in pediatric patients with advanced solid tumors

Pediatric Blood & Cancer ◽

10.1002/pbc.24278 ◽

2012 ◽

Vol 60 (2) ◽

pp. 230-236 ◽

Cited By ~ 4

Author(s):

Margaret E. Macy ◽

Tracey Duncan ◽

James Whitlock ◽

Stephen P. Hunger ◽

Jessica Boklan ◽

...

Keyword(s):

Solid Tumors ◽

Pediatric Patients ◽

Advanced Solid Tumors ◽

Phase Ib

Download Full-text

Study of 2-hydroxyoleic Acid in Pediatric Patients With Malignant Glioma and Other Advanced Solid Tumors

Case Medical Research ◽

10.31525/ct1-nct04299191 ◽

2020 ◽

Author(s):

Keyword(s):

Malignant Glioma ◽

Solid Tumors ◽

Pediatric Patients ◽

Advanced Solid Tumors

Download Full-text

Phase IB Dose-Escalation Study of BEZ235 or BKM120 in Combination with Paclitaxel (PTX) in Patients With Advanced Solid Tumors

Annals of Oncology ◽

10.1016/s0923-7534(20)33012-x ◽

2012 ◽

Vol 23 ◽

pp. ix157-ix158

Author(s):

L. Dirix ◽

M. Schuler ◽

J. Machiels ◽

D. Hess ◽

A. Awada ◽

...

Keyword(s):

Solid Tumors ◽

Dose Escalation ◽

Advanced Solid Tumors ◽

Dose Escalation Study ◽

Phase Ib

Download Full-text

Phase Ib Study of Combination Therapy with MEK Inhibitor Binimetinib and Phosphatidylinositol 3‐Kinase Inhibitor Buparlisib in Patients with Advanced Solid Tumors with RAS/RAF Alterations

The Oncologist ◽

10.1634/theoncologist.2019-0297 ◽

2019 ◽

Vol 25 (1) ◽

Cited By ~ 10

Author(s):

Aditya Bardia ◽

Mrinal Gounder ◽

Jordi Rodon ◽

Filip Janku ◽

Martijn P. Lolkema ◽

...

Keyword(s):

Combination Therapy ◽

Solid Tumors ◽

Kinase Inhibitor ◽

Mek Inhibitor ◽

Advanced Solid Tumors ◽

Phosphatidylinositol 3 Kinase ◽

Phase Ib ◽

Phosphatidylinositol 3

Download Full-text

A phase Ib trial with MK-8628/OTX015, a small molecule inhibitor of bromodomain (BRD) and extra-terminal (BET) proteins, in patients with selected advanced solid tumors

European Journal of Cancer ◽

10.1016/s0959-8049(16)32609-0 ◽

2016 ◽

Vol 69 ◽

pp. S2-S3 ◽

Cited By ~ 14

Author(s):

C. Massard ◽

J.C. Soria ◽

A. Stathis ◽

J.P. Delord ◽

A. Awada ◽

...

Keyword(s):

Solid Tumors ◽

Small Molecule ◽

Small Molecule Inhibitor ◽

Advanced Solid Tumors ◽

Phase Ib ◽

Molecule Inhibitor

Download Full-text

Phase Ib Study of High-dose Intermittent Afatinib in Patients With Advanced Solid Tumors

Clinical Lung Cancer ◽

10.1016/j.cllc.2018.04.015 ◽

2018 ◽

Vol 19 (5) ◽

pp. e655-e665 ◽

Cited By ~ 2

Author(s):

D. Ross Camidge ◽

Lecia V. Sequist ◽

Pasi A. Jänne ◽

Andrew J. Weickhardt ◽

Elizabeth S. Dowling ◽

...

Keyword(s):

Solid Tumors ◽

High Dose ◽

Advanced Solid Tumors ◽

Phase Ib

Download Full-text

Abstract CT167: A Phase Ib study to assess safety, tolerability, pharmacokinetics, and preliminary antitumor activity of sitravatinib in combination with tislelizumab in patients with advanced solid tumors

10.1158/1538-7445.am2019-ct167 ◽

2019 ◽

Author(s):

Jeffrey Goh ◽

Ben Gao ◽

Ben Markman ◽

Hui Gan ◽

Mark Voskoboynik ◽

...

Keyword(s):

Antitumor Activity ◽

Solid Tumors ◽

Advanced Solid Tumors ◽

Phase Ib

Download Full-text

Abstract CT157: Phase IB study of nivolumab and veliparib in patients with advanced solid tumors and lymphoma with and without alterations in selected DNA repair genes

10.1158/1538-7445.am2020-ct157 ◽

2020 ◽

Author(s):

Elena Vagia ◽

Pedro Viveiros ◽

Cyra-Yoonsun Kang ◽

Aparna Kalyan ◽

Valerie Nelson ◽

...

Keyword(s):

Dna Repair ◽

Solid Tumors ◽

Advanced Solid Tumors ◽

Dna Repair Genes ◽

Phase Ib ◽

Repair Genes

Download Full-text

A Phase Ib multicenter, dose-escalation study of the polyamine analogue PG-11047 in combination with gemcitabine, docetaxel, bevacizumab, erlotinib, cisplatin, 5-fluorouracil, or sunitinib in patients with advanced solid tumors or lymphoma

Cancer Chemotherapy and Pharmacology ◽

10.1007/s00280-020-04201-1 ◽

2020 ◽

Author(s):

Tracy Murray Stewart ◽

Daniel Von Hoff ◽

Michael Fitzgerald ◽

Laurence J. Marton ◽

Carlos H. Roberto Becerra ◽

...

Keyword(s):

Solid Tumors ◽

Dose Escalation ◽

Advanced Solid Tumors ◽

Dose Escalation Study ◽

Phase Ib ◽

Polyamine Analogue

Download Full-text

A phase Ib, open-label study to assess the safety of continuous oral treatment with afatinib in combination with two chemotherapy regimens: cisplatin plus paclitaxel and cisplatin plus 5-fluorouracil, in patients with advanced solid tumors

Annals of Oncology ◽

10.1093/annonc/mds633 ◽

2013 ◽

Vol 24 (5) ◽

pp. 1392-1400 ◽

Cited By ~ 30

Author(s):

J.B. Vermorken ◽

S. Rottey ◽

E. Ehrnrooth ◽

K. Pelling ◽

A. Lahogue ◽

...

Keyword(s):

Solid Tumors ◽

Oral Treatment ◽

Advanced Solid Tumors ◽

Open Label ◽

Open Label Study ◽

Label Study ◽

Phase Ib

Download Full-text

Final results of a phase Ib trial of PR104, a pre-prodrug of the bioreductive prodrug PR104A, in combination with gemcitabine (G) or docetaxel (D) in patients with advanced solid tumors.

Journal of Clinical Oncology ◽

10.1200/jco.2010.28.15_suppl.2554 ◽

2010 ◽

Vol 28 (15_suppl) ◽

pp. 2554-2554 ◽

Cited By ~ 4

Author(s):

M. B. Jameson ◽

M. J. McKeage ◽

R. K. Ramanathan ◽

J. Rajendran ◽

Y. Gu ◽

...

Keyword(s):

Solid Tumors ◽

Advanced Solid Tumors ◽

Phase Ib

Download Full-text